In recent years, the treatment spectrum for patients with inflammatory bowel disease (IBD) has expanded significantly. Based on the recognition that chronic and untreated inflammation adversely affects disease progression, early drug intervention and intensive monitoring are nowadays advocated to prevent complications.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Cardiovascular risk in IBD
Cause for concern?
- Microplastics in kidneys and urine
Life in plastic … is not fantastic
- Asthma and psyche
When fear makes you lose your breath
- COPD: Update for the primary care physician
Counteract exacerbations and improve quality of life
- Stroke
Not on the brain – the latest findings on strokes
- Atopic dermatitis: choice of systemic therapy option
“It’s always an individual weighing”.
- Do low carb diets harm the heart?
Keto diet associated with hypercholesterolemia and increased risk of ASCVD
- Cardiovascular events in CKD